Kenneth H. Grabstein
38Patents
14h-index
47Co-inventors
81Inventor score
Filing activity: Jul 30, 1986 → Dec 18, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5078996A | Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor | Emerging Cross-Sectional Technologies | 111 | Expired |
| US5552303A | DNA encoding epithelium-derived T-cell factor | Chemistry; Metallurgy | 65 | Expired |
| US7067132B2 | Antagonists of interleukin-15 | Chemistry; Metallurgy | 53 | Expired |
| US5574138A | Epithelium-derived T-cell factor | Human Necessities | 46 | Expired |
| US5747024A | Vaccine adjuvant comprising interleukin-15 | Human Necessities | 37 | Expired |
| US5795966A | Antagonists of interleukin-15 | Human Necessities | 31 | Expired |
| US6013480A | Antagonists of interleukin-15 | Human Necessities | 28 | Expired |
| US5122459A | Gene encoding biologically active human interleukin 1 | Emerging Cross-Sectional Technologies | 23 | Expired |
| US6168783A | Antagonists of interleukin-15 | Human Necessities | 22 | Expired |
| US8568706B2 | Modified human interferon-beta polypeptides | Emerging Cross-Sectional Technologies | 22 | Active |
| US5162111A | Treatment of bacterial diseases with granulocyte-macrophage colony stimulating factor | Emerging Cross-Sectional Technologies | 22 | Expired |
| US5707616A | Method for treating or preventing gastrointestinal disease with epithelium-derived T-cell factor | Human Necessities | 19 | Expired |
| US7235240B2 | Antagonists of interleukin-15 | Chemistry; Metallurgy | 18 | Expired |
| US7829659B2 | Methods of modifying polypeptides comprising non-natural amino acids | Emerging Cross-Sectional Technologies | 15 | Active |
| US5892001A | Epithelium-derived T-cell factor antibodies | Human Necessities | 14 | Expired |
| US6184359A | Antibodies to epithelium-derived T-cell factor | Human Necessities | 14 | Expired |
| US6165466A | Antagonists of interleukin-15 | Human Necessities | 14 | Expired |
| US9670521B2 | Amino acid derivatives | Chemistry; Metallurgy | 12 | Active |
| US7632492B2 | Modified human interferon-β polypeptides | Emerging Cross-Sectional Technologies | 11 | Active |
| US5985262A | Method of treatment with epithelium derived T-cell factor | Human Necessities | 10 | Expired |
| US6177079A | Antagonists of interleukin-15 | Human Necessities | 8 | Expired |
| US5660824A | Muscle trophic factor | Human Necessities | 8 | Expired |
| US4882282A | DNA sequences encoding bovine interleukin-2 | Chemistry; Metallurgy | 5 | Expired |
| US5474769A | Treatment of microbial infection by monocyte stimulation with interleukin-7 | Human Necessities | 4 | Expired |
| US9732367B2 | Cell lines | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.